Exercise price per share or per unit of warrants or rights outstanding.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.

+ References

No definition available.

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsidiarySaleOfStockLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

+ Details

Name:	us-gaap_WarrantsAndRightsOutstandingTerm
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted average price per share amount at which grantees can acquire shares of common stock by exercise of warrants.

+ References

No definition available.

+ Details

Name:	vani_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice
Namespace Prefix:	vani_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.

+ References

No definition available.

+ Details

Name:	vani_ClassOfWarrantOrRightOutstandingIntrinsicValue
Namespace Prefix:	vani_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The element represents class of warrants or rights term.

+ References

No definition available.

+ Details

Name:	vani_ClassOfWarrantsOrRightsTerm
Namespace Prefix:	vani_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The gross proceeds of cash inflow from issuance of common stock and warrants in connection with securities purchase agreement during the reporting period.

+ References

No definition available.

+ Details

Name:	vani_ProceedsFromIssuanceOfCommonStockAndWarrantsInConnectionWithSecuritiesPurchaseAgreementGross
Namespace Prefix:	vani_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=vani_SecuritiesPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=vani_NanoPrecisionMedicalIncWarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=vani_RightOfferingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Warrants (Details Narrative) - USD ($) $ / shares in Units, $ in Millions		1 Months Ended			12 Months Ended
	Mar. 01, 2024	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Securities Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Gross proceeds	$ 15.0
Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Weighted Average Exercise Price Per Share, Issued						$ 3.8
Exercise price per share					$ 3.49	$ 3.42	$ 11.6
Warrant [Member] \| Securities Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price per share	$ 3.8
Intrinsic value					$ 0.0
Warrants and Rights Outstanding, Term	3 years
Gross proceeds	$ 15.0
Warrant [Member] \| Securities Purchase Agreement [Member] \| Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Number of warrants convertible	3,947,368
Nano Precision Medical Inc Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Number of securities called by each warrant					1
Weighted Average Exercise Price Per Share, Issued		$ 3.15	$ 3.15	$ 3.15	$ 3.15
Exercise price per share					$ 3.15
Right Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Term of warrants					5 years